Hyperactive Osteoclasts Cause Osteoporosis In Neurofibromatosis Type 1 Patients

Main Category: Genetics
Also Included In: Bones / Orthopedics
Article Date: 24 Oct 2006 - 22:00 PDT

Current ratings for:
'Hyperactive Osteoclasts Cause Osteoporosis In Neurofibromatosis Type 1 Patients'

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Neurofibromatosis type 1 (NF1) is a relatively common genetic disorder (around 1 per 3,000 births) caused by inheriting one mutated copy of the gene NF1. Individuals with NF1 exhibit a range of symptoms, the most severe of which are tumors that grow along certain types of nerves. However, other symptoms, including osteoporosis, are also seen in some individuals.

To understand why individuals expressing only one copy of NF1 (NF1+/-) develop osteoporosis, Wade Clapp and colleagues from Indiana University generated mice expressing only one copy of Nf1 (Nf1+/- mice). Nf1+/- mice were found to have increased numbers of osteoclasts, which are cells that degrade and resorb bone. These osteoclasts were better at surviving, proliferating, and degrading bone than osteoclasts from normal mice. These abnormal characteristics were associated with increased activity of two signaling molecules, p21ras and PI3K. Importantly, in this study, which appears online on October 19 in advance of publication in the November print issue of the Journal of Clinical Investigation, it was shown that osteoclasts from individuals with NF1 have the same characteristics as osteoclasts from Nf1+/- mice. This study not only provides insight into why individuals with NF1 suffer from osteoporosis, but also leads the authors to suggest that targeting PI3K might be a viable therapy for treating all individuals with osteoporosis.

TITLE: Hyperactivity of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions

AUTHOR CONTACT:

D. Wade Clapp
Indiana University School of Medicine, Indianapolis, Indiana, USA.

Feng-Chun Yang
Indiana University School of Medicine, Indianapolis, Indiana, USA.

###

JCI table of contents: October 19, 2006

Contact: Karen Honey
Journal of Clinical Investigation

Article adapted by Medical News Today from original press release.
Visit our genetics section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Karen Honey. "Hyperactive Osteoclasts Cause Osteoporosis In Neurofibromatosis Type 1 Patients." Medical News Today. MediLexicon, Intl., 24 Oct. 2006. Web.
26 May. 2012. <http://www.medicalnewstoday.com/releases/54699.php>

APA
Karen Honey. (2006, October 24). "Hyperactive Osteoclasts Cause Osteoporosis In Neurofibromatosis Type 1 Patients." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/54699.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Hyperactive Osteoclasts Cause Osteoporosis In Neurofibromatosis Type 1 Patients'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Genetics

Most Popular Articles



Follow Our Genetics News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Genetics Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »